PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Priority review for Merck & Co’s belzutifan in rare kidney cancer subset

Merck & Co has received a priority review from the US Food and Drug Administration (FDA) for its potential rare kidney cancer treatment belzutifan. Belzutifan, a...
Continue Reading →
News

HRA Pharma Rare Diseases funds online hub for Cushing’s Syndrome

HRA Pharma Rare Diseases, an affiliate of global consumer healthcare company HRA Pharma, has announced it is funding an online platform containing information and ne...
Continue Reading →
News

EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events

Several authorities responsible for national vaccine campaigns in EU countries have temporarily paused vaccination with COVID-19 Vaccine AstraZeneca. This is a preca...
Continue Reading →
News

Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Conditional Marketing Authorization by European Commission

Data have demonstrated vaccine protects against COVID-19 related hospitalisation in broad geographic regions, including those with emerging variants [i] Decision fol...
Continue Reading →
News

Leinco Technologies, Inc. and La Jolla Institute for Immunology announce license agreement to develop novel COVID-19 diagnostic tools

La Jolla Institute for Immunology (LJI), one of the leading research organizations dedicated to studying the immune system announced today that it has signed a ...
Continue Reading →
News

Noble Joins the Human Factors MEdical DevIce Consortium to Bolster Its Commitment to Developing Safer and More Effective Medical Devices

University-led organization aims to improve medical device efficacy through human-centered design  Noble, an Aptar Pharma company, has joined the&n...
Continue Reading →
News

NICE rejects AZ’s Lynparza for metastatic prostate cancer

The UK’s National Institute for Health and Care Excellence’s (NICE) appraisal committee has chosen not to recommend AstraZeneca’s (AZ) PARP inhibitor Lynparza for BR...
Continue Reading →
News

Researchers identify early changes in BRCA1-positive breast cells

A new study has found that BRCA1-positive breast cells appear to undergo changes before becoming cancerous, which could help identify which patients can benefit from...
Continue Reading →
News

Positive opinion from CHMP for Lilly’s COVID-19 antibodies

Eli Lilly have announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion fo...
Continue Reading →
News

Spring-free simplicity for higher volumes: the new UniSafe® safety device for 2.25mL prefilled syringes

As new biological therapies are developed, further advancing the treatment of chronic conditions, drug delivery devices must also keep up the pace of innovation....
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026